Overcoming the immortality of tumour cells by telomere and telomerase based cancer therapeutics – current status and future prospects
Open Access
- 1 May 2005
- journal article
- review article
- Published by Elsevier in European Journal Of Cancer
- Vol. 41 (7) , 971-979
- https://doi.org/10.1016/j.ejca.2004.11.024
Abstract
No abstract availableKeywords
This publication has 76 references indexed in Scilit:
- “Of mice and men”European Journal Of Cancer, 2004
- A DNA damage checkpoint response in telomere-initiated senescenceNature, 2003
- Identification of a quinoxaline derivative that is a potent telomerase inhibitor leading to cellular senescence of human cancer cellsBiochemical Journal, 2003
- Mechanism of Human Telomerase Inhibition by BIBR1532, a Synthetic, Non-nucleosidic Drug CandidateJournal of Biological Chemistry, 2002
- Expression of mutant telomerase in immortal telomerase-negative human cells results in cell cycle deregulation, nuclear and chromosomal abnormalities and rapid loss of viabilityOncogene, 2001
- The Hallmarks of CancerCell, 2000
- Extension of Life-Span by Introduction of Telomerase into Normal Human CellsScience, 1998
- Telomerase Catalytic Subunit Homologs from Fission Yeast and HumanScience, 1997
- Specific Association of Human Telomerase Activity with Immortal Cells and CancerScience, 1994
- Hypervariable ultra-long telomeres in miceNature, 1990